Categories: Research

Method to predict polypharmacology developed in Shoichet Lab

A computational method developed in the UCSF School of Pharmacy under the direction of faculty member Brian Shoichet, PhD, has the potential to predict new target diseases for existing drugs as well as unexpected side effects of approved drugs.

UCSF innovation among top 10 for 2009

The Scientist has cited a UCSF innovation among its top 10 list of tools to hit the life sciences in 2009. In the spotlight is a paper that reveals how to import plant "light switches" into mammalian cells to control complex regulatory processes. The paper appeared in the October 15, 2009 issue of...

Craik to lead Takeda-sponsored research on antibodies

Takeda San Francisco, Inc., announced September 21, 2009 that it has entered into a sponsored collaboration with UCSF to support antibody-related research in the laboratory of Charles S.

Kroetz discusses pharmacogenomics on KQED Quest radio

UCSF researcher Deanna Kroetz, PhD, discusses the impact of genetic differences on how an individual responds to drugs in a KQED Quest radio interview that aired September 14, 2009.

Study identifies lack of information about HER2 testing practices

Breast cancer patients might not be getting full advantage from a genetic screening test for the protein known as HER2 to help determine if the use of trastuzumab (marketed as Herceptin) is the best course of treatment for them. For patients whose breast cancer cells produce excessive amounts of...

UCSF researchers join consortium to target cancer in new ways

Scientists from the UCSF School of Pharmacy's Department of Pharmaceutical Chemistry have been selected to lead a new federal initiative aimed at developing new classes of drugs to target cancer.

Voigt Lab programs bacteria to perform increasingly complicated tasks

UCSF School of Pharmacy researchers and colleagues have successfully created a mathematical model that genetically programs bacteria and causes the bacteria to "trace" images projected onto them in a petri dish. The bacteria sense and display the area of the projection where light meets dark by...

Bero serves on IOM committee that reports on conflict of interest

UCSF School of Pharmacy researcher Lisa Bero, PhD, served with UCSF School of Medicine colleagues Bernard Lo, MD, and Deborah Grady,

Two circuits found responsible for a cell’s ability to adapt

UCSF researchers have identified the two key circuits, compared to hundreds as previously thought, that control a cell's ability to adapt to changes in its environment. These circuits are key to a cell's ability to reset itself after responding to a stimulus.

New drug targeted for Kaposi’s sarcoma

A team of scientists from UCSF and colleagues have identified a new potential drug target for the herpes virus that causes Kaposi’s sarcoma. Their research reopens the possibility of using a class of drugs called protease inhibitors, against diseases ranging from cancer to Alzheimer's Disease.

Pages